The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Consulting or Advisory Role - Argos Therapeutics
Travel, Accommodations, Expenses - Merck
Treatment trends of localized renal cell carcinoma by hospital type: A NCDB analysis.
 
David B. Cahn
No Relationships to Disclose
 
Elizabeth Handorf
Research Funding - Pfizer (Inst); Pfizer (Inst)
 
Daniel C. Edwards
No Relationships to Disclose
 
Laura Kidd
No Relationships to Disclose
 
Daniel M. Geynisman
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Brian T. Kadow
No Relationships to Disclose
 
Richard E. Greenberg
No Relationships to Disclose
 
Rosalia Viterbo
No Relationships to Disclose
 
David Chen
No Relationships to Disclose
 
Alexander Kutikov
Employment - Visible Health
Leadership - Visible Health
Stock and Other Ownership Interests - Visible Health
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Genomic Health
 
Robert Uzzo
Consulting or Advisory Role - Genentech/Roche; Johnson & Johnson; Pfizer
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis
 
Marc C. Smaldone
No Relationships to Disclose